Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Scott C. Borinstein, M.D., Ph. D.

Assistant Professor of Pediatrics
(Pediatric Hematology and Oncology)
VICC Member
Pediatric Hematologist/Oncologist

Profile

Dr. Borinstein's research focuses on the development of better treatment for pediatric sarcomas. Specifically, his laboratory investigates how changes in DNA methylation contribute to the pathogenesis of Ewing Sarcoma. DNA methylation is an epigenetic mechanism that contributes to the regulation of genes.
Read more ....

Dr. Borinstein's research focuses on the development of better treatment for pediatric sarcomas. Specifically, his laboratory investigates how changes in DNA methylation contribute to the pathogenesis of Ewing Sarcoma. DNA methylation is an epigenetic mechanism that contributes to the regulation of genes. His laboratory is trying to understand how DNA methylation contributes to Ewing Sarcoma tumor formation and spread and to determine if methylation of certain genes could play a role in diagnosis, treatment, or the development of novel treatments for this disease.

Education
  • M.D. - Medical College of Virginia, Virginia Commonwealth University (MCV/VCU), Richmond, VA,
  • Ph.D. - Medical College of Virginia, Virginia Commonwealth University (MCV/VCU), Richmond, VA
  • Pediatric Residency-Seattle Children's Hospital, Seattle, WA
  • Pediatric Hematology/Oncology Fellowship-Seattle Children's Hospital, Seattle, WA